Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 18 | 22 | +4 |
| Shares | 1.32M | 369.5K | −950.7K (−72.0%) |
| Value | $1.97M | $194.1K | −$1.78M (−90.2%) |
New holders (8)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Holos Integrated Wealth LLC | 32,480 | $16.6K | 0.01% |
| Susquehanna International Group, LLP | 23,802 | $12.1K | 0.00% |
| Renaissance Technologies LLC | 18,170 | $9.27K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,102 | $562 | 0.00% |
| SBI Securities Co., Ltd. | 11 | $6 | 0.00% |
| GWM Advisors LLC | 1 | $1 | 0.00% |
| IFP Advisors, Inc | 2 | $1 | 0.00% |
| Royal Bank of Canada | 35 | $0 | 0.00% |
Sold out (4)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Highbridge Capital Management LLC | 128,956 | $456.5K |
| Squarepoint Ops LLC | 20,601 | $72.9K |
| JTC Employer Solutions Trusteee Ltd | 775,000 | $72.0K |
| Sanctuary Advisors, LLC | 10,004 | $6.16K |